Literature DB >> 17187063

Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo.

Tudor A Fulga1, Ilan Elson-Schwab, Vikram Khurana, Michelle L Steinhilb, Tara L Spires, Bradley T Hyman, Mel B Feany.   

Abstract

Hyperphosphorylated forms of the microtubule-associated protein (MAP) tau accumulate in Alzheimer's disease and related tauopathies and are thought to have an important role in neurodegeneration. However, the mechanisms through which phosphorylated tau induces neurodegeneration have remained elusive. Here, we show that tau-induced neurodegeneration is associated with accumulation of filamentous actin (F-actin) and the formation of actin-rich rods in Drosophila and mouse models of tauopathy. Importantly, modulating F-actin levels genetically leads to dramatic modification of tau-induced neurodegeneration. The ability of tau to interact with F-actin in vivo and in vitro provides a molecular mechanism for the observed phenotypes. Finally, we show that the Alzheimer's disease-linked human beta-amyloid protein (Abeta) synergistically enhances the ability of wild-type tau to promote alterations in the actin cytoskeleton and neurodegeneration. These findings raise the possibility that a direct interaction between tau and actin may be a critical mediator of tau-induced neurotoxicity in Alzheimer's disease and related disorders.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17187063     DOI: 10.1038/ncb1528

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  187 in total

1.  Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.

Authors:  Sylvia E Perez; Damianka P Getova; Bin He; Scott E Counts; Changiz Geula; Laurent Desire; Severine Coutadeur; Helene Peillon; Stephen D Ginsberg; Elliott J Mufson
Journal:  Am J Pathol       Date:  2011-12-03       Impact factor: 4.307

2.  Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration.

Authors:  Brian R Hoover; Miranda N Reed; Jianjun Su; Rachel D Penrod; Linda A Kotilinek; Marianne K Grant; Rose Pitstick; George A Carlson; Lorene M Lanier; Li-Lian Yuan; Karen H Ashe; Dezhi Liao
Journal:  Neuron       Date:  2010-12-22       Impact factor: 17.173

3.  Lamin Dysfunction Mediates Neurodegeneration in Tauopathies.

Authors:  Bess Frost; Farah H Bardai; Mel B Feany
Journal:  Curr Biol       Date:  2015-12-24       Impact factor: 10.834

Review 4.  Actin dynamics and cofilin-actin rods in alzheimer disease.

Authors:  James R Bamburg; Barbara W Bernstein
Journal:  Cytoskeleton (Hoboken)       Date:  2016-03-01

5.  The γ-secretase modulator CHF5074 reduces the accumulation of native hyperphosphorylated tau in a transgenic mouse model of Alzheimer's disease.

Authors:  Annamaria Lanzillotta; Ilenia Sarnico; Marina Benarese; Caterina Branca; Cristina Baiguera; Birgit Hutter-Paier; Manfred Windisch; Pierfranco Spano; Bruno Pietro Imbimbo; Marina Pizzi
Journal:  J Mol Neurosci       Date:  2010-12-22       Impact factor: 3.444

6.  The neuronal p35 activator of Cdk5 is a novel F-actin binding and bundling protein.

Authors:  Lisheng He; Zhaojun Zhang; Yan Yu; Sohail Ahmed; Nam Sang Cheung; Robert Z Qi
Journal:  Cell Mol Life Sci       Date:  2010-10-26       Impact factor: 9.261

7.  Tau phosphorylation at Alzheimer's disease-related Ser356 contributes to tau stabilization when PAR-1/MARK activity is elevated.

Authors:  Kanae Ando; Mikiko Oka; Yosuke Ohtake; Motoki Hayashishita; Sawako Shimizu; Shin-Ichi Hisanaga; Koichi M Iijima
Journal:  Biochem Biophys Res Commun       Date:  2016-08-09       Impact factor: 3.575

8.  Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alpha-synucleinopathy.

Authors:  Chee Yeun Chung; James B Koprich; Hasan Siddiqi; Ole Isacson
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

Review 9.  ADF/Cofilin-actin rods in neurodegenerative diseases.

Authors:  J R Bamburg; B W Bernstein; R C Davis; K C Flynn; C Goldsbury; J R Jensen; M T Maloney; I T Marsden; L S Minamide; C W Pak; A E Shaw; I Whiteman; O Wiggan
Journal:  Curr Alzheimer Res       Date:  2010-05       Impact factor: 3.498

Review 10.  Transgenic Drosophila models of Alzheimer's disease and tauopathies.

Authors:  Kanae Iijima-Ando; Koichi Iijima
Journal:  Brain Struct Funct       Date:  2009-12-05       Impact factor: 3.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.